CLINICAL TRIAL WITH PROPHYLACTIC TENOFOVIR FOR HAEMATOLOGICAL CANCER PATIENTS SHOWING A HBc-Ab POSITIVE AND HBs-Ag PATTERN AND TO BE TREATED WITH RITUXIMAB (PREBLIN STUDY)
Latest Information Update: 02 Dec 2021
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms PREBLIN
- Sponsors Gilead Sciences
- 17 Apr 2016 Results presented at The International Liver Congress 2016
- 17 Apr 2016 Status changed from recruiting to completed, as per the results presented at The International Liver Congress™ 2016.
- 12 Apr 2014 Interim results (n=25) presented at the 49th Annual Meeting of the European Association for the Study of the Liver.